1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsPage highlights 'FY26 OCRP Funding Opportunities Now Available' and links to detailed funding opportunity pages and eBRAP portal for pre-applications.
Ovarian Cancer Investigator-Initiated Research Award is sponsored by Department of Defense (DoD) - Congressionally Directed Medical Research Programs (CDMRP). This opportunity supports mission-aligned projects and measurable outcomes.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Ovarian Cancer Research Program, Congressionally Directed Medical Research Programs You are using an outdated browser. Please upgrade your browser to improve your experience. U.S. Department of War organization.
Due to routine system maintenance the CDMRP website will be unavailable from COB 24 April - 27 April COB.
DEPARTMENT OF WAR - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS Transforming Health Care through Innovative and Impactful Research Vision – To eliminate ovarian cancer Mission – To support research to prevent, detect, treat, cure and optimally survive ovarian cancer to enhance the well-being of Service Members, Veterans, retirees, their Family members, and all women impacted by this disease » Click on Image to View Summary Sheet The Department of Defense (DOD) Ovarian Cancer Research Program (OCRP) was initiated in FY97 to support high-impact, cutting-edge research that fills unmet needs.
The OCRP establishes priorities to target the most critical needs along the research development pipeline from basic to translational to clinical research, including clinical trials, and to push the field of ovarian cancer forward to our vision to “eliminate ovarian cancer. ” Ovarian cancer is the fifth leading cause of cancer-related death in women, with the risk of acquiring the disease during her lifetime of 1 in 78.
In 2022, approximately 19,880 women will be diagnosed with ovarian cancer in the United States, and an estimated 12,810 will die from the disease. * According to the recent ten-year Military Health System (MHS) data, over 300 active Service Members encountered ovarian cancer. MHS data further uncovers over 20,000 DOD beneficiaries were diagnosed with ovarian cancer.
OCRP’s current research Areas of Emphasis include: Understand the basic biology and etiology of ovarian cancer initiation, progression, metastasis, recurrence, genetics and other critical events. Develop novel therapeutic strategies for treatment and prevention. Identify and develop new strategies for screening, early-stage detection, prevention, accurate diagnosis and prognosis.
Identify and implement strategies to improve survivorship and quality of life. Improve precision medicine. *American Cancer Society, https://www.
cancer. org/cancer/ovarian-cancer/about/key-statistics.
html Congressional Appropriations Recent Applications Recommended for Funding FY25 Peer Review Participants [Click on Image to Watch on DVIDS] The OCRP Clinical Trials Academy [Click on Image to Watch on DVIDS] The Ovarian Cancer Academy: Realizing the Vision [Click on Image to Watch on DVIDS] FY25 OCRP Recommended for Funding List CDMRP Accelerates Advancements in Cancer Screening for Warfighters, Veterans and the Nation CDMRP-FUNDED RESEARCH SEEKS TO UNDERSTAND THE CONNECTION BETWEEN PSYCHOLOGICAL DISTRESS AND OVARIAN CANCER Ovarian Cancer Reseach Program Booklet Falloposcope: A Minimally Invasive Tool for Early Ovarian Cancer Detection Dr. Meredith Mitstifer: Taking Ovarian Cancer Awareness and Hope to New Heights Sachia Powell - OCRP Consumer Reviewer Mary Beth Mudrick - I Survived and I Thrived!
Click here to provide feedback/comments to the OCRP Last updated Wednesday, May 13, 2026
According to the current listing, eligibility includes: Independent investigators at nonprofit and academic research institutions at all career levels. Confirm the full requirements in the official notice before applying.
The current listing shows up to $1,400,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Ovarian Cancer Investigator-Initiated Research Award is funded by Department of Defense (DoD) - Congressionally Directed Medical Research Programs (CDMRP). Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
CDMRP's FY26 portfolio funds 34 programs, and October 2026 is dense with full-application deadlines: PRCRP October 5, PCRP October 7, MRP October 14. Every one of them is gated behind a pre-application that closed months earlier. Here is what that two-step structure actually costs applicants, and how to be inside the gate for FY27.
Read articleCDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read articleThe memorandum of agreement was signed August 4 and 5, disclosed by House appropriators on September 3, and runs through 2036. It names no dollar figure. Here is what is actually established, what is still speculation, and what researchers holding or planning NIAID biodefense awards should do before September 30.
Read article